Ovarian cancer: the duplicity of CA125 measurement
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://www.nature.com/articles/nrclinonc.2010.44.pdf
Reference64 articles.
1. Bast, R. C. Jr et al. Reactivity of a monoclonal antibody with human ovarian carcinoma. J. Clin. Invest. 6 8, 1331–1337 (1981).
2. Bast, R. C. Jr et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N. Engl. J. Med. 309, 883–887 (1983).
3. Partridge, E. et al. Results from four rounds of ovarian cancer screening in a randomized trial. Obstet. Gynecol. 113, 775–782 (2009).
4. Menon, U. et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 10, 327–340 (2009).
5. Rustin, G. J., van der Burg, M. E., on behalf of MRC and EORTC collaborators. A randomized trial in ovarian cancer (OC) of early treatment of relapse based on CA125 level alone versus delayed treatment based on conventional clinical indicators (MRC OV05/EORTC 55955 trials) [abstract]. J. Clin. Oncol. 27 (Suppl. 18s), a1 (2009).
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prediction of ovarian cancer prognosis using statistical radiomic features of ultrasound images;Physics in Medicine & Biology;2024-06-07
2. Histologic variants in bladder cancer harbor aggressive molecular features including TM4SF1 expression and a CA125+ cell state;2024-05-21
3. Noninvasive serum N-glycans associated with ovarian cancer diagnosis and precancerous lesion prediction;Journal of Ovarian Research;2024-01-27
4. Noninvasive early differential diagnosis and progression monitoring of ovarian cancer using the copy number alterations of plasma cell-free DNA;Translational Research;2023-12
5. Advances in Exosomal microRNAs and Proteins in Ovarian Cancer Diagnosis, Prognosis, and Treatment;Current Molecular Medicine;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3